Novotech Launches Dedicated Early Phase Unit for Biotechs Leveraging the Australian and New Zealand Clinical Environment Novotech launches a dedicated early-phase strategic delivery unit focussed on leveraging the unique advantage of ANZ for early-phase clinical development